drugset / Trial / NCT01670552

Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients

NCT01670552

Phase 3 Completed 490 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety of an association with one anti-inflammatory and one gastroprotective agent compared to the one anti-inflammatory and one gastroprotective agent in patients with acute or chronic osteoarticular inflammation.

Timeline

Start
2016-02-17
Primary completion
2016-10-28
Completion
2017-03-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esomeprazole Small molecule 20 mg
Comparator Naproxen Small molecule 500 mg
Subject Nimesulide Small molecule 100 mg
Subject Pantoprazole Other / unclassified 20 mg

Indications